Other Clinical Trial - Pathophysiology of Inborn Immunodeficiencies

Status Recruiting

Clinical Trial Summary

The pathophysiology of primary immunodeficiencies (PID), which encompass a broad range of different diseases with susceptibility to infection and/or a deregulated inflammatory response, is poorly understood. Available treatments are often not specific for a distinct target and might be associated with side effects. To elucidate pathophysiology of different PIDs, stool, urine, blood, tissue biopsies and/or bone marrow will be collected and analysed for anti-microbial activity and inflammatory response. In a second step, targeted treatment for different PIDs might be developed preclinically and ex vivo according to underlying pathophysiology.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Immunologic Deficiency Syndromes
Primary Immune Deficiency Disorder

Clinical Trial Details

NCT number	NCT03422614
Study type	Observational
Source	University of Zurich
Contact	Janine Reichenbach, Prof. Dr.
Phone	+41442667311
Email	janine.reichenbach@kispi.uzh.ch
Status	Recruiting
Phase	N/A
Start date	July 1, 2015
Completion date	July 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03939533` - Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases	Phase 3
Recruiting	`NCT03266640` - Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)	Phase 2
Recruiting	`NCT03266627` - Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection	Phase 2
Completed	`NCT01859754` - Octagam 5% Versus Comparator Post Marketing Trial
Recruiting	`NCT03148028` - Immunological Characteristics of Patients With PID and IBD	N/A
Active, not recruiting	`NCT04354818` - Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA)
Completed	`NCT03988426` - Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases	Phase 3
Completed	`NCT01888484` - Study of Octanorm Subcutaneous IG in Patients With PID	Phase 3
Completed	`NCT01131858` - Study of Vitamin D3 Substitution to Patients With Primary Immunodeficiency	Phase 1/Phase 2
Completed	`NCT03211689` - The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease	N/A
Terminated	`NCT01883921` - Gamma Globulin Observations and Outcomes Database for Patients With Primary Immunodeficiency Disease (GOOD-SHEPARD-PI)
Recruiting	`NCT03266653` - EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection	Phase 2
Completed	`NCT02327351` - TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID	Phase 2/Phase 3
Completed	`NCT03618147` - Primary Immunodeficiency in Kuwait
Recruiting	`NCT04197596` - Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)	Phase 1/Phase 2
Completed	`NCT02888535` - Intensive Care Unit and Secondary and Primary Immune Deficiency
Recruiting	`NCT04232085` - Reduced Intensity BMT for Immune Dysregulatory and Bone Marrow Failure Syndromes Using Post-Transplant Cyclophosphamide	Phase 2
Active, not recruiting	`NCT03037359` - A Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globulin Products
Completed	`NCT03069079` - Investigation of Dental Health in Children With Neutrophil Defects: A Clinical Study	N/A
Recruiting	`NCT03414528` - Identification of New Inborn Errors of Immunity	N/A